ArticleHemaSphere2020

Carfilzomib Combined With Thalidomide and Low-dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed Transplant Eligible Patients With Multiple Myeloma: 8 vs 4 Induction Cycles; the Carthadex Trial.

Ruth Wester et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.